Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Creating immunity

Susan Fletcher
CMAJ August 19, 2003 169 (4) 282-283;
Susan Fletcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The argument in a CMAJ editorial1 that “Unless a large proportion (usually over 95%) of the population is vaccinated, herd immunity will not result and outbreaks will recur” had me scratching my head. The same editorial notes that “the near-complete immunization of whole populations in childhood has led, decades later, to whole populations of adults with waning immunity to some childhood diseases,” giving as an example pertussis, which “is now as common among adults as among children.” This is not the first time that the efficacy of vaccines has been called into question.

“Herd immunity” was defined in the first half of the last century as protection of any given population from a transmissible disease, through lifelong or long-term immunity caused by contraction of and recovery from the disease;2 immunity related to high standards of nutrition, cleanliness and sanitation was a cofactor.3 As the case of pertussis and other examples show, herd immunity through vaccination is a flawed concept. For various reasons, the efficacy of vaccines is highly variable (and never complete), and any immunity derived from vaccines is only short-lived.4

It wouldn't be so bad if all we had to worry about was lack of efficacy — after all, we managed to survive for thousands of years with no vaccinations. However, the fact that these agents of dubious effect are also harmful is another matter. However, recent data from the US Vaccine Adverse Event Reporting System show that deaths following pertussis vaccine far surpass deaths from pertussis (20 deaths yearly from the disease, 57 following vaccinations, which is a gross understatement because only 10% of reactions — at most — are reported).2

I agree that we need national leadership on vaccination policy and a much improved national system of recording morbidity and mortality related to specific diseases. Much more pressing is the need for an adverse reaction reporting system that encompasses all possible adverse events and is easily accessed by the general public. What we don't need is multitudes of expensive new vaccines on top of the many we already have, within an already faltering health care system.

Susan Fletcher Vaccination Risk Awareness Network Inc. Sechelt, BC

References

  1. 1.↵
    A patchwork policy: vaccination in Canada [editorial]. CMAJ 2003;168(5):533.
    OpenUrlFREE Full Text
  2. 2.↵
    Tenpenny SJ. Vaccines — what CDC documents and science reveals [video]. Strongsville (OH): New Medical Awareness Seminars; 2002.
  3. 3.↵
    James W. Immunization: the reality behind the myth. 2nd ed. Westport (CT): Praeger Publishers; 1995.
  4. 4.↵
    Fine P. Herd immunity: history, theory, practice. Epidemiol Rev 1993;15(2):265-302.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 169 (4)
CMAJ
Vol. 169, Issue 4
19 Aug 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Creating immunity
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Creating immunity
Susan Fletcher
CMAJ Aug 2003, 169 (4) 282-283;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Creating immunity
Susan Fletcher
CMAJ Aug 2003, 169 (4) 282-283;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Succinylcholine, malignant hyperthermia and rhabdomyolysis
  • Study authors don’t consider waning SARS-CoV-2 immunity after vaccination in their model
  • The authors respond to criticisms of their model parameters
Show more Letters

Similar Articles

Collections

  • Topics
    • Canadian government
    • Vaccination

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire